Form 4: Genprex CEO Ryan Confer Reports Routine Stock Transaction for Tax Withholding

Genprex, Inc. President, CEO, and CFO Ryan M. Confer reported a disposition of 5,775 shares of common stock on June 30, 2025, to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Ryan M. Confer, who serves as President, CEO, and CFO, and is also a Director and 10% Owner of Genprex, Inc. (GNPX), filed a Form 4.
• The transaction occurred on June 30, 2025, and involved the disposition of 5,775 shares of Genprex Common Stock.
• The shares were disposed of at a price of $0.2279 per share.
• This disposition was specifically for satisfying tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units (RSUs).
• The RSUs were granted under the Genprex, Inc. 2018 Equity Incentive Plan.
• Following this transaction, Ryan M. Confer directly beneficially owns 32,968 shares of Genprex Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares for tax withholding purposes related to RSU vesting, which is a common occurrence for executives receiving equity compensation. It does not indicate a discretionary sale or purchase, thus maintaining a neutral sentiment.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of an insider's stock transaction, specifically related to tax withholding on RSU vesting. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related disposition by an executive and is unlikely to have a significant direct impact on the company's share price or long-term value. It reflects the normal course of equity compensation.

Key Dates

Keywords

Genprex, GNPX, Form 4, Insider Transaction, Ryan Confer, Restricted Stock Units, RSU vesting, Tax withholding, Beneficial ownership, Equity Incentive Plan